JESSLYNN MANNINO: Open Payments
NPI 1366193252 · DEER PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 20 payments from 12 companies in 2025. Trend: 2023 $823 · 2024 $376 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $155 |
| Novartis Pharmaceuticals Corporation | 4 | $133 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $124 |
| Amgen Inc. | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Lilly USA, LLC | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
Products named: LEQVIO, ULTOMIRIS, DUPIXENT, TEZSPIRE, Repatha, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
